In anemic patients who have undergone PCI, non-adherence to dual antiplatelet therapy is associated with a higher risk of major adverse cardiovascular events in the two years following the procedure, researchers say.
In anemic patients who have undergone PCI, non-adherence to dual antiplatelet therapy is associated with a higher risk of major adverse cardiovascular events in the two years following the procedure, researchers say.
In anemic patients who have...